JPS5927341B2 - Purification/separation method - Google Patents

Purification/separation method

Info

Publication number
JPS5927341B2
JPS5927341B2 JP52101966A JP10196677A JPS5927341B2 JP S5927341 B2 JPS5927341 B2 JP S5927341B2 JP 52101966 A JP52101966 A JP 52101966A JP 10196677 A JP10196677 A JP 10196677A JP S5927341 B2 JPS5927341 B2 JP S5927341B2
Authority
JP
Japan
Prior art keywords
fluorouracil
uracil
solution
hydrofluoric acid
separating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP52101966A
Other languages
Japanese (ja)
Other versions
JPS5436281A (en
Inventor
越勉 上吹
正幸 浅岡
祥二 高木
正道 香川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daikin Industries Ltd
Original Assignee
Daikin Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daikin Kogyo Co Ltd filed Critical Daikin Kogyo Co Ltd
Priority to JP52101966A priority Critical patent/JPS5927341B2/en
Publication of JPS5436281A publication Critical patent/JPS5436281A/en
Publication of JPS5927341B2 publication Critical patent/JPS5927341B2/en
Expired legal-status Critical Current

Links

Description

【発明の詳細な説明】 本発明は精製・分離方法、更に詳しくは少なくともウラ
シルと5−フルオロウラシルを含む混合物から5−フル
オロウラシルを高純度で精製・分離する方法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a purification and separation method, and more particularly to a method for purifying and separating 5-fluorouracil with high purity from a mixture containing at least uracil and 5-fluorouracil.

5−フルオロウラシルは、自体制癌剤として、また他の
制癌剤の合成中間体として有用な物質であつて、その性
質上高純度のものが要求される。
5-Fluorouracil is a substance useful both as an anticancer agent itself and as a synthetic intermediate for other anticancer agents, and due to its nature, high purity is required.

従来、この5−フルオロウラシルは液状媒体中に溶解乃
至懸濁させたウラシルにフッ素またはこれに類するフッ
素化剤、例えばトリフルオロメチルハイポフルオライト
等を反応させて製造されることが知られている。これら
の反応によつて得られる粗製品中には、目的とする5−
フルオロウラシル以外に、通常、未反応の原料ウラシル
やウラシルの過フッ素化物等の副生物が含まれているの
で、5−フルオロウラシルの純度を高める為に、適宜の
精製手段を適用することが必要である。
Conventionally, it has been known that 5-fluorouracil is produced by reacting uracil dissolved or suspended in a liquid medium with fluorine or a similar fluorinating agent such as trifluoromethylhypofluorite. The crude product obtained by these reactions contains the desired 5-
In addition to fluorouracil, it usually contains by-products such as unreacted raw material uracil and perfluorinated products of uracil, so it is necessary to apply appropriate purification methods to increase the purity of 5-fluorouracil. .

しかしながら、このような粗製5−フルオロウラシルの
精製に際しウラシルと5−フルオロウラシルの分離は極
めて困難であつて、これまで比較的好ましい精製手段と
されている粗製5−フルオロウラシルを水から晶析せし
める方法ですら、不純物として混在するウラシルを除く
ことは殆ど不可能であつた。つまり、これまでにウラシ
ルと5−フルオロウラシルを分離するための適当な方法
は見出されていないのが実情である。そこで、前記の反
応において、ウラシルの転化率を上げて粗製物中の未反
応ウラシルの含量をできる限り少なくする方法が試みら
れたが、ウラシルの転化率を上げれば反応未期における
フツ素化を継続することとなり、その結果未反応ウラシ
ルはある程度減少するもののそれにも増して5−フルオ
ロウラシルのフツ素化が進行し、ウラシルのジフルオロ
体等の副生物が生成し、5−フルオロウラシルの純度向
上と云う本来の目的が達成されないのみか、その収率も
低下すると云う望ましくない結果がもたらされた。
However, in purifying such crude 5-fluorouracil, it is extremely difficult to separate uracil and 5-fluorouracil, and even the method of crystallizing crude 5-fluorouracil from water, which has been considered a relatively preferable purification method, has been difficult. It was almost impossible to remove uracil mixed in as an impurity. In other words, the reality is that no suitable method for separating uracil and 5-fluorouracil has been found so far. Therefore, in the above reaction, attempts have been made to increase the conversion rate of uracil to minimize the content of unreacted uracil in the crude product, but increasing the conversion rate of uracil reduces fluorination in the early stage of the reaction. As a result, although the amount of unreacted uracil decreases to some extent, the fluorination of 5-fluorouracil progresses even more, and by-products such as the difluoro form of uracil are produced, resulting in an improvement in the purity of 5-fluorouracil. Not only was the original purpose not achieved, but the yield was also reduced, which was an undesirable result.

このように、粗製の5−フルオロウラシルから未反応ウ
ラシルを除去し、高純度の5−フルオロウラシルを得る
ことのできる方法の出現が望まれていたのであるが、本
発明者らは鋭意検討した結果、ウラシルと5−フルオロ
ウラシルを含む混合物をフツ酸水溶液を溶媒として晶析
分離する方法により、驚くべきことに、前記の混合物か
ら顕著にウラシルを除去することができ、高純度の5−
フルオロウラシルが得られると云う事実を見出した。
As described above, it has been desired to develop a method that can remove unreacted uracil from crude 5-fluorouracil and obtain highly pure 5-fluorouracil, and as a result of intensive study, the present inventors found that Surprisingly, by crystallizing and separating a mixture containing uracil and 5-fluorouracil using an aqueous hydrofluoric acid solution as a solvent, uracil can be significantly removed from the mixture, resulting in highly pure 5-fluorouracil.
We have discovered the fact that fluorouracil can be obtained.

このような事実は前記従来の水を溶媒とする晶析分離方
法の知見からは全く予期し得ないことである。本発明は
、かかる事実の発見に基づいて完成されたものであつて
、その要旨とするところは、少なくともウラシルと5−
フルオロウラシルを含む混合物をフツ酸水溶液に溶解さ
せ、得られた溶液から5−フルオロウラシルを晶析分離
することを特徴とする前記混合物から5−フルオロウラ
シルを高純度で精製・分離する方法にある。
Such a fact is completely unexpected from the knowledge of the conventional crystallization separation method using water as a solvent. The present invention was completed based on the discovery of this fact, and its gist is that at least uracil and 5-5-
A method for purifying and separating 5-fluorouracil with high purity from the mixture, comprising dissolving a mixture containing fluorouracil in an aqueous hydrofluoric acid solution and crystallizing and separating 5-fluorouracil from the resulting solution.

本発明の方法によれば、ウラシルと5−フルオロウラシ
ルを含む混合物からウラシルを除去して高純度の5−フ
ルオロウラシルを容易かつ収率よく精製・分離すること
ができるので、前述した如きウラシルの転化率を上げる
必要もなく、その結果反応時間の短縮ならびに副生物の
減少による収率の向上が達成される。
According to the method of the present invention, it is possible to remove uracil from a mixture containing uracil and 5-fluorouracil and purify and separate high-purity 5-fluorouracil with ease and high yield, so that the conversion rate of uracil as described above can be achieved. As a result, the reaction time is shortened and the yield is improved due to a reduction in by-products.

更に本発明の方法においては、脱色も同時に行われ、従
来の水による晶析分離の場合にも必要であつた脱色工程
が不要となり、またフツ酸水溶液の高溶解性能の為、水
の場合に比べ処理能力が大巾に増加すると云う利点があ
る。本発明の方法は、ウラシルと5−フルオロウラシル
を含む混合物の精製分離において使用できるが、通常、
前記ウラシルのフツ素化によつて製造される粗製5−フ
ルオロウラシルの精製・分離に用いられる。
Furthermore, in the method of the present invention, decolorization is carried out at the same time, eliminating the need for the decolorization step that was also necessary in the case of conventional crystallization separation using water. It has the advantage of greatly increasing processing power. The method of the present invention can be used in the purification and separation of mixtures containing uracil and 5-fluorouracil, but usually
It is used for the purification and separation of crude 5-fluorouracil produced by the fluorination of uracil.

更に、該フツ素化反応をフツ酸水溶液中で行う方法によ
り得られる粗製5−フルオロウラシルに適用する場合に
は、反応液をそのま\晶析分離することにより高純度の
5−フルオロウラシルを得ることができるので、特に有
利である。5−フルオロウラシル製造のためのウラシル
のフツ素化には、種々の方法が採用され得るが、一般に
液体媒体(水、酢酸、トリフルオロ酢酸、パーフルオロ
アセトン等の極性溶媒)中、ウラシルにフツ素またはこ
れに類するフツ素化剤、たとえばトリフルオロメチルハ
イポフルオライトなどを反応させる方法が用いられる。
Furthermore, when applying the fluorination reaction to crude 5-fluorouracil obtained by performing the fluorination reaction in an aqueous hydrofluoric acid solution, highly pure 5-fluorouracil can be obtained by directly crystallizing and separating the reaction solution. It is particularly advantageous because it allows Various methods can be employed to fluorinate uracil for the production of 5-fluorouracil, but generally uracil is fluorinated in a liquid medium (polar solvent such as water, acetic acid, trifluoroacetic acid, perfluoroacetone, etc.). Alternatively, a method may be used in which a similar fluorinating agent such as trifluoromethyl hypofluorite is reacted.

特に本出願人らが先に完成した発明方法(特公昭54−
3875号)の採用が工業生産上の効率の点で推奨され
よう。しかして、本発明の最も好ましい実施態様として
は、50〜85重量%のフツ酸水溶液中に溶解及至懸濁
させたウラシルに、15℃以下であつて当該フツ酸水溶
液の凝固点以上の温度でフツ素を反応させ、得られた反
応混合物を一旦前記の反応温度よりも高く、かつ室温〜
80℃程度に加温することにより粗製5−フルオロウラ
シルのフツ酸水溶液を得、次いでこの液をそのま\冷却
させて5−フルオロウラシルを晶析分離する方法が挙げ
られる。本発明方法において、5−フルオロウラシルの
晶析に用いられる溶媒としては、フツ酸水溶液であれば
特に制限されないが、30〜85重量%の濃度を有する
フツ酸水溶液がより好ましく用いられる。
In particular, the method of invention completed by the present applicants (Japanese Patent Publication Publication No. 1983-
3875) is recommended from the viewpoint of industrial production efficiency. Therefore, in the most preferred embodiment of the present invention, uracil dissolved or suspended in a 50 to 85% by weight aqueous hydrofluoric acid solution is added to uracil at a temperature of 15° C. or below and above the freezing point of the hydrofluoric acid aqueous solution. and the resulting reaction mixture is heated to a temperature higher than the above reaction temperature and from room temperature to
An example of a method is to obtain a hydrofluoric acid aqueous solution of crude 5-fluorouracil by heating to about 80°C, and then to cool this solution as it is to crystallize and separate 5-fluorouracil. In the method of the present invention, the solvent used for crystallizing 5-fluorouracil is not particularly limited as long as it is an aqueous hydrofluoric acid solution, but an aqueous hydrofluoric acid solution having a concentration of 30 to 85% by weight is more preferably used.

フツ酸濃度が30重量%より低いときはウラシルの分離
が十分に達成され難く、85重量%より高いときは蒸気
圧が急増し、装置上の問題などで取扱い難い。また、晶
析は通常冷却することにより行われる。冷却温度は原料
混合物の溶解温度以下が採用できるが、室温以下の温度
で低温になるほど5−フルオロウラシルの回収率が向上
するので好ましく、使用する溶媒の凝固点以下の温度は
使用できない。以下に実施例と比較例を挙げて本発明を
更に具体的に説明する。
When the hydrofluoric acid concentration is lower than 30% by weight, it is difficult to achieve sufficient separation of uracil, and when it is higher than 85% by weight, the vapor pressure increases rapidly, making it difficult to handle due to equipment problems. Moreover, crystallization is usually performed by cooling. The cooling temperature can be below the dissolution temperature of the raw material mixture, but it is preferable to use a temperature below room temperature because the recovery rate of 5-fluorouracil improves as the temperature decreases, and temperatures below the freezing point of the solvent used cannot be used. EXAMPLES The present invention will be described in more detail below with reference to Examples and Comparative Examples.

たマし、%とあるのは重量%である。実施例1〜7およ
び比較例1〜2 第1表に示す所定の条件下に、粗製5−フルオロウラシ
ルをフツ酸水溶液に完全に溶解し、得られた溶液を冷却
して5−フルオロウラシルを晶析せしめ、次いで淵別分
離後、乾燥して精製5−フルオロウラシルの白色結晶を
得た。
% is weight %. Examples 1 to 7 and Comparative Examples 1 to 2 Under the predetermined conditions shown in Table 1, crude 5-fluorouracil was completely dissolved in an aqueous hydrofluoric acid solution, and the resulting solution was cooled to crystallize 5-fluorouracil. After separation, the mixture was separated and dried to obtain white crystals of purified 5-fluorouracil.

その結果を第1表に示す。比較の為、水を溶媒として上
記とほぼ同様の操作を行い、その結果を第1表に併記す
る。
The results are shown in Table 1. For comparison, almost the same operation as above was performed using water as a solvent, and the results are also listed in Table 1.

ただし、この場合、得られた結晶は着色していた。なお
、粗製および精製5−フルオロウラシルの組成割合は液
体クロマトグーラフにより分析した結果である(以下同
様)。
However, in this case, the obtained crystals were colored. The composition ratios of crude and purified 5-fluorouracil are the results of analysis using a liquid chromatograph (the same applies hereinafter).

実施例 8〜9 攪拌器、冷却器、ガス吹込口および温度計を備えた20
0m1のダイフロン樹脂(ダイキン工業(株):製トリ
フルオロクロロエチレン樹脂)製フラスコに、65%の
フツ酸水溶液中に原料ウラシルを10%溶解させたもの
を入れ、−5゜Cに温度を維持しながら、攪拌下に窒素
ガスで稀釈したフツ素ガスを通じた。
Examples 8-9 20 equipped with stirrer, cooler, gas inlet and thermometer
A 10% solution of raw material uracil in a 65% hydrofluoric acid aqueous solution was placed in a 0 ml flask made of Daiflon resin (trifluorochloroethylene resin manufactured by Daikin Industries, Ltd.), and the temperature was maintained at -5°C. While stirring, fluorine gas diluted with nitrogen gas was passed through.

Claims (1)

【特許請求の範囲】 1 少なくともウラシルと5−フルオロウラシルを含む
混合物をフッ酸水溶液に溶解させ、得られた溶液から5
−フルオロウラシルを晶析分離することを特徴とする前
記混合物から5−フルオロウラシルを高純度で精製・分
離する方法。 2 フッ酸水溶液が30〜85重量%の濃度からなるも
のである前記第1項記載の方法。 3 得られた溶液を冷却することにより5−フルオロウ
ラシルを晶析せしめる前記第1項記載の方法。 4 室温以下であつて、フッ酸水溶液の凝固点以上の温
度を冷却する前記第3項記載の方法。 5 少なくともウラシルと5−フルオロウラシルを含む
混合物が液状媒体中、ウラシルにフッ素またはトリフル
オロメチルハイポフルオライトを反応させて得られた反
応混合物から液状媒体を除いたものである前記第1項記
載の方法。 6 50〜85重量%のフッ酸水溶液中、15℃以下で
あつて、フッ酸水溶液の凝固点以上の温度でウラシルに
フッ素を反応させ得られた反応液を、一旦前記反応温度
より高くかつ室温〜80℃に加温し、得られた反応液を
そのまま冷却して、5−フルオロウラシルを晶析分離す
ることを特徴とする前記反応液から5−フルオロウラシ
ルを高純度で精製・分離する方法。
[Claims] 1. A mixture containing at least uracil and 5-fluorouracil is dissolved in an aqueous hydrofluoric acid solution, and from the resulting solution, 5-fluorouracil is dissolved.
- A method for purifying and separating 5-fluorouracil with high purity from the aforementioned mixture, which comprises crystallizing and separating fluorouracil. 2. The method according to item 1 above, wherein the hydrofluoric acid aqueous solution has a concentration of 30 to 85% by weight. 3. The method according to item 1 above, wherein 5-fluorouracil is crystallized by cooling the obtained solution. 4. The method according to item 3, wherein the temperature is below room temperature and above the freezing point of the hydrofluoric acid aqueous solution. 5. The method according to item 1 above, wherein the mixture containing at least uracil and 5-fluorouracil is a reaction mixture obtained by reacting uracil with fluorine or trifluoromethylhypofluorite in a liquid medium, with the liquid medium removed. . 6. The reaction solution obtained by reacting uracil with fluorine in a 50 to 85% by weight aqueous hydrofluoric acid solution at a temperature below 15°C and above the freezing point of the aqueous hydrofluoric acid solution is heated once above the reaction temperature and from room temperature to room temperature. A method for purifying and separating 5-fluorouracil with high purity from the reaction solution, which comprises heating the reaction solution to 80° C., cooling the obtained reaction solution as it is, and crystallizing and separating 5-fluorouracil.
JP52101966A 1977-08-25 1977-08-25 Purification/separation method Expired JPS5927341B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP52101966A JPS5927341B2 (en) 1977-08-25 1977-08-25 Purification/separation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP52101966A JPS5927341B2 (en) 1977-08-25 1977-08-25 Purification/separation method

Publications (2)

Publication Number Publication Date
JPS5436281A JPS5436281A (en) 1979-03-16
JPS5927341B2 true JPS5927341B2 (en) 1984-07-05

Family

ID=14314601

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52101966A Expired JPS5927341B2 (en) 1977-08-25 1977-08-25 Purification/separation method

Country Status (1)

Country Link
JP (1) JPS5927341B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0541475B2 (en) * 1983-11-22 1993-06-23 Yamaha Motor Co Ltd

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0541475B2 (en) * 1983-11-22 1993-06-23 Yamaha Motor Co Ltd

Also Published As

Publication number Publication date
JPS5436281A (en) 1979-03-16

Similar Documents

Publication Publication Date Title
JP3085776B2 (en) How to recover adipic acid
JPH0684332B2 (en) Method for optical resolution of a-isopropyl-p-chlorophenylacetic acid
JPS6351358A (en) Production of ditertiary butyl dicarbonate
JPH07110827B2 (en) Method for producing tetrabromobisphenol A
JPS5927341B2 (en) Purification/separation method
JP2845745B2 (en) Production method of high purity methanesulfonyl fluoride
JPH08225485A (en) Method of obtaining adipic acid
JPS5949217B2 (en) Method for producing substituted diphenyl ether
US3931316A (en) Method of preparing O-methyl-isourea hydrogen sulfate and O-methyl-isourea sulfate from cyanamide
JPS6121455B2 (en)
JPS5944302B2 (en) Mutual separation method of threonine and allothreonine
JPS5829305B2 (en) Marei Midono Seizouhou
US2738352A (en) Purification of pyridine compounds
US3130223A (en) Process for preparing phenacetin
JPH0425265B2 (en)
JPH069488A (en) Production of 2,4,5-trihalobenzoic acid
JPH03190847A (en) Purification of 3,4-dichloronitrobenzene
JPS60210519A (en) Method for purifying and obtaining sulfamide
US3498760A (en) Process for the purification of nitrosyl hydrogen pyrosulfate(nohs2o7)
JPS6267067A (en) Production of 1,1'-peroxydicyclopentylamine
JPS5896035A (en) Purification of phloroglucin
JPS6126787B2 (en)
JPH0259142B2 (en)
JPH04173785A (en) 2-chloropropionaldehyde trimer and its production
JPH02282345A (en) Production of 2,4,5-trifluorobenzoic acid